Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | FASN | P49327 | 1/20 | 0.39 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.35 |
| ▸ | FAAH | O00519 | 4/20 | 0.34 |
| ▸ | F7 | P08709 | 2/20 | 0.34 |
| ▸ | F3 | P13726 | 2/20 | 0.34 |
| ▸ | MAPT | P10636 | 2/20 | 0.34 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.34 |
| ▸ | OXER1 | Q8TDS5 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.34 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9633750 | 1.00 | ALDH1A1 (0.40) | ALDH1A1TSHRFASNTRPA1FAAH | |
| SCHEMBL31141319 | 1.00 | ALDH1A1 (0.40) | ALDH1A1TSHRFASNTRPA1FAAH | |
| SCHEMBL27211790 | 1.00 | ALDH1A1 (0.40) | ALDH1A1TSHRFASNTRPA1FAAH | |
| SCHEMBL31141187 | 1.00 | ALDH1A1 (0.40) | ALDH1A1TSHRFASNTRPA1FAAH | |
| SCHEMBL21483849 | 0.86 | ALDH1A1 (0.50) | ALDH1A1TSHRFASNFAAHF7 | |
| SCHEMBL21483999 | 0.86 | ALDH1A1 (0.50) | ALDH1A1TSHRFASNFAAHF7 | |
| SCHEMBL21483879 | 0.86 | ALDH1A1 (0.50) | ALDH1A1TSHRFASNFAAHF7 | |
| SCHEMBL21484006 | 0.86 | ALDH1A1 (0.50) | ALDH1A1TSHRFASNFAAHF7 | |
| SCHEMBL21483983 | 0.86 | ALDH1A1 (0.50) | ALDH1A1TSHRFASNFAAHF7 | |
| SCHEMBL21483947 | 0.86 | ALDH1A1 (0.50) | ALDH1A1TSHRFASNFAAHF7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4365159-B1 | ORGANOHALOGEN COMPOUND HAVING CONJUGATED DOUBLE BOND, PROCESS FOR PREPARING ACETATE COMPOUND AND ALCOHOL COMPOUND THEREOF, AND COMPOUND USED TO SYNTHESIZE THE ORGANOHALOGEN COMPOUND | SHINETSU CHEMICAL CO (JP) | 2025-12-03 | — | — | EP | disclosed |
| US-20240262943-A1 | PROCESS FOR PREPARING CONJUGATED DIENE COMPOUND UTILIZING INTRAMOLECULAR SIGMATROPIC REARRANGEMENT REACTION | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2024-08-08 | — | — | US | disclosed |
| US-20240174701-A1 | ORGANOHALOGEN COMPOUND HAVING CONJUGATED DOUBLE BOND, PROCESS FOR PREPARING ACETATE COMPOUND AND ALCOHOL COMPOUND THEREOF, AND COMPOUND USED TO SYNTHESIZE THE ORGANOHALOGEN COMPOUND | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2024-05-30 | — | — | US | disclosed |
| EP-4365159-A1 | ORGANOHALOGEN COMPOUND HAVING CONJUGATED DOUBLE BOND, PROCESS FOR PREPARING ACETATE COMPOUND AND ALCOHOL COMPOUND THEREOF, AND COMPOUND USED TO SYNTHESIZE THE ORGANOHALOGEN COMPOUND | Shin-Etsu Chemical Co., Ltd. (JP) | 2024-05-08 | — | — | EP | disclosed |
| CN-117924017-A | Organic halogen compound having conjugated double bond, method for preparing acetate and alcohol derivative thereof, and compound for synthesizing the compound | 信越化学工业株式会社 | 2024-04-26 | — | — | CN | disclosed |
| EP-0241335-B1 | 1-SUBSTITUTED CONJUGATED ALKA-(E,Z)-DIENE COMPOUNDS AND A METHOD FOR THE PREPARATION THEREOF | Shin-Etsu Chemical Co., Ltd. (JP) | 1992-06-03 | — | — | EP | disclosed |
| EP-0241335-A1 | 1-substituted conjugated alka-(E,Z)-diene compounds and a method for the preparation thereof | Shin-Etsu Chemical Co., Ltd. (JP) | 1987-10-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240174701-A1 | ORGANOHALOGEN COMPOUND HAVING CONJUGATED DOUBLE BOND, PROCESS FOR PREPARING ACETATE COMPOUND AND ALCOHOL COMPOUND THEREOF, AND COMPOUND USED TO SYNTHESIZE THE ORGANOHALOGEN COMPOUND | ADH5, ADH1C, ADH1A | ALDH1A1 16/4885TSHR 911/4885FASN 466/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.